help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kins, S.
Right arrow Articles by Götz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kins, S.
Right arrow Articles by Götz, J.
(American Journal of Pathology. 2003;163:833-843.)
© 2003 American Society for Investigative Pathology

Activation of the ERK and JNK Signaling Pathways Caused by Neuron-Specific Inhibition of PP2A in Transgenic Mice

Stefan Kins, Pascal Kurosinski, Roger M. Nitsch and Jürgen Götz

From the Division of Psychiatry Research, University of Zürich, Zürich, Switzerland

A reduced activity of protein phosphatase 2A (PP2A) has been shown in brains of patients with Alzheimer’s disease (AD), a neurodegenerative disorder characterized histopathologically by amyloid plaques and neurofibrillary tangles. Tau, as the principal component of neurofibrillary tangles, can be hyperphosphorylated by a reduced activity of PP2A in vitro and by pharmacological approaches, suggesting a crucial role of PP2A in tangle formation. To dissect the role of PP2A in vivo, we previously generated transgenic mice with chronically reduced PP2A activity by expressing a dominant-negative mutant form of the PP2A catalytic subunit C{alpha}, L199P, under the control of a neuron-specific promoter. In these mice, endogenous tau is phosphorylated at the epitopes Ser202/Thr205 and Ser422. In vitro, these tau phospho-epitopes can be phosphorylated by the kinases ERK and JNK, and the kinases themselves are negatively regulated by PP2A. In this study, we show that chronic inhibition of PP2A activity in L199P transgenic mice causes the activation of ERK and JNK as demonstrated by the phosphorylation and nuclear accumulation of the ERK and JNK substrates, Elk-1 and c-Jun. TUNEL staining revealed that activated JNK signaling was not associated with cell death. Our findings imply that PP2A is a negative regulator of the ERK and JNK signaling pathways in vivo, suggesting that in AD, tau hyperphosphorylation may be caused in part by PP2A dysfunction.





This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Puustinen, M. R. Junttila, S. Vanhatupa, A. A. Sablina, M. E. Hector, K. Teittinen, O. Raheem, K. Ketola, S. Lin, J. Kast, et al.
PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A-Mediated Inactivation in Human Malignant Glioma
Cancer Res., April 1, 2009; 69(7): 2870 - 2877.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Sato, J. Xu, S. Okuyama, L. B. Martinez, S. M. Walsh, M. T. Jacobsen, R. J. Swan, J. D. Schlautman, P. Ciborowski, and T. Ikezu
Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1
J. Neurosci., December 31, 2008; 28(53): 14511 - 14521.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. D. Show, C. M. Hill, M. D. Anway, W. W. Wright, and B. R. Zirkin
Phosphorylation of Mitogen-Activated Protein Kinase 8 (MAPK8) Is Associated With Germ Cell Apoptosis and Redistribution of the Bcl2-Modifying Factor (BMF)
J Androl, May 1, 2008; 29(3): 338 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, B. Li, I. Grundke-Iqbal, and K. Iqbal
I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A
J. Biol. Chem., April 18, 2008; 283(16): 10513 - 10521.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. R. Junttila, S.-P. Li, and J. Westermarck
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
FASEB J, April 1, 2008; 22(4): 954 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. C. Chao, Y. L. Ma, and E. H. Y. Lee
Protein Kinase CK2 Impairs Spatial Memory Formation through Differential Cross Talk with PI-3 Kinase Signaling: Activation of Akt and Inactivation of SGK1
J. Neurosci., June 6, 2007; 27(23): 6243 - 6248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
B.-K. Chen, C.-C. Huang, W.-C. Chang, Y.-J. Chen, U. Kikkawa, K.-i. Nakahama, I. Morita, and W.-C. Chang
PP2B-mediated Dephosphorylation of c-Jun C Terminus Regulates Phorbol Ester-induced c-Jun/Sp1 Interaction in A431 Cells
Mol. Biol. Cell, March 1, 2007; 18(3): 1118 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Shi, Y.-J. Chiu, Y. Cho, T. A. Bullard, M. Sokabe, and K. Fujiwara
Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch
Cardiovasc Res, March 1, 2007; 73(4): 813 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Kuan, T. Gruebl, P. Soba, S. Eggert, I. Nesic, S. Back, J. Kirsch, K. Beyreuther, and S. Kins
PAT1a Modulates Intracellular Transport and Processing of Amyloid Precursor Protein (APP), APLP1, and APLP2
J. Biol. Chem., December 29, 2006; 281(52): 40114 - 40123.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K.-J. Yin, C. Y. Hsu, X.-Y. Hu, H. Chen, S.-W. Chen, J. Xu, and J.-M. Lee
Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death.
J. Neurosci., February 22, 2006; 26(8): 2290 - 2299.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. D. Yi, J. Chung, P. Pang, and J. W. Simpkins
Role of Protein Phosphatases in Estrogen-Mediated Neuroprotection
J. Neurosci., August 3, 2005; 25(31): 7191 - 7198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Tanimukai, I. Grundke-Iqbal, and K. Iqbal
Up-Regulation of Inhibitors of Protein Phosphatase-2A in Alzheimer's Disease
Am. J. Pathol., June 1, 2005; 166(6): 1761 - 1771.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
K. D. Cygnar, X. Gao, D. Pan, and T. P. Neufeld
The Phosphatase Subunit Tap42 Functions Independently of Target of Rapamycin to Regulate Cell Division and Survival in Drosophila
Genetics, June 1, 2005; 170(2): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. N. Hancock, S. Dangi, and P. Shapiro
Protein Phosphatase 2A Activity Associated with Golgi Membranes during the G2/M Phase May Regulate Phosphorylation of ERK2
J. Biol. Chem., March 25, 2005; 280(12): 11590 - 11598.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Salahshor and J R Woodgett
The links between axin and carcinogenesis
J. Clin. Pathol., March 1, 2005; 58(3): 225 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Levinthal and D. B. DeFranco
Reversible Oxidation of ERK-directed Protein Phosphatases Drives Oxidative Toxicity in Neurons
J. Biol. Chem., February 18, 2005; 280(7): 5875 - 5883.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Goral and E. J. Kovacs
In Vivo Ethanol Exposure Down-Regulates TLR2-, TLR4-, and TLR9-Mediated Macrophage Inflammatory Response by Limiting p38 and ERK1/2 Activation
J. Immunol., January 1, 2005; 174(1): 456 - 463.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-J. Pei, C.-X. Gong, W.-L. An, B. Winblad, R. F. Cowburn, I. Grundke-Iqbal, and K. Iqbal
Okadaic-Acid-Induced Inhibition of Protein Phosphatase 2A Produces Activation of Mitogen-Activated Protein Kinases ERK1/2, MEK1/2, and p70 S6, Similar to That in Alzheimer's Disease
Am. J. Pathol., September 1, 2003; 163(3): 845 - 858.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.